X4 Pharmaceuticals XFOR Stock Chart Pattern Insight X4 Pharmaceuticals posts 379 EPS beat with narrower loss The Southern Company SO Marks 25th Consecutive Dividend Increase Reinforces Defensive Income Investment Thesis MIAX Miami delivers 243 percent Q4 2025 EPS beat shares rise 084 percent in regular trading today